Events

Looking forward to attending BIO International Convention 2026 in San Diego and meeting colleagues across the biotech, pharmaceutical, investment, academic, nonprofit, and government communities. At AiViva BioPharma, we are advancing two clinical-stage programs: AIV007, a periocular, sustained-release lenvatinib therapy being developed for retinal vascular diseases, including wet AMD and DME. AIV001, an intradermally administered axitinib…